Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Neurovascular Embolization Coils Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Neurovascular Embolization Coils Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Medical Devices & Consumables
Published Date: 2026-08-23
Pages: 172 Pages
Report ld: 6994681
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
KEY FINDINGS
Intracranial aneurysm embolization remains the principal clinical demand for Neurovascular Embolization Coils
Product differentiation increasingly centers on complex geometry, softness, packing efficiency, and controllable detachment
Detachable coils dominate commercial neurovascular coiling, with mechanical and electrolytic detachment technologies coexisting
North America remains a leading high-value market, while Asia Pacific is gaining strategic importance
Competition combines established multinational neurovascular platforms with an expanding group of Chinese manufacturers
Neurovascular Embolization Coils Market Size(US$)
CAGR 2026-2032
5.6%
Market Size,2032
USD 1,553
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 1,120 million
Market Forecast in 2032(Value)
US$ 1,553 million
CAGR
5.6%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Neurovascular Embolization Coils market is projected to grow from US$ 1058 million in 2025 to US$ 1553 million by 2032, at a CAGR of 5.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Neurovascular Embolization Coils are implantable neurointerventional devices delivered through a microcatheter into intracranial or other neurovascular lesions to mechanically fill the target space, promote local thrombus formation, and reduce or permanently occlude abnormal blood flow. The implant is generally constructed from radiopaque platinum or platinum-based alloys and engineered into complex three-dimensional, helical, or other secondary shapes, with different coil diameters, lengths, softness levels, and packing characteristics designed for framing, filling, and finishing during embolization. Mainstream systems use controllable mechanical or electrolytic detachment, while selected products incorporate hydrogel, polymer fibers, or other enhancement technologies to improve volumetric filling, conformability, or thrombogenic performance. The market primarily covers sterile single-use detachable neurovascular embolization coil systems used in endovascular treatment of intracranial aneurysms, with additional applications in cerebral arteriovenous malformations, arteriovenous fistulae, and other approved neurovascular abnormalities. Product differentiation is driven by coil geometry, softness, detachment reliability, packing efficiency, microcatheter compatibility, radiopacity, and the ability to provide predictable deployment in anatomically complex lesions.
MARKET TRENDS
Neurovascular Embolization Coils are evolving from relatively standardized platinum implants toward highly differentiated coil platforms optimized for specific stages of aneurysm embolization. Manufacturers are expanding complex three-dimensional framing designs, ultra-soft filling and finishing coils, longer and higher-volume configurations, and low-profile products compatible with smaller microcatheters. Product development increasingly emphasizes predictable wall apposition, reduced catheter kickback, improved packing density, controlled deployment, and rapid, reliable detachment. Bare-metal platinum and platinum-alloy coils remain the foundation of the market, while hydrogel, polymer-fiber, and other enhanced coil technologies provide additional differentiation in selected clinical settings. Another important direction is portfolio integration: major neurovascular companies increasingly position coils together with microcatheters, coil-assist stents, balloons, access devices, and other aneurysm treatment technologies, strengthening procedural compatibility and hospital-level account penetration rather than competing solely on the individual coil.
MARKET SEGMENTATION
By Company
- Stryker Corporation
- Medtronic plc
- Johnson & Johnson
- Terumo Corporation
- Penumbra, Inc.
- Balt Group
- Kaneka Corporation
- Genesis MedTech Group
- MicroPort NeuroScientific Corporation
- Wallaby Medical Holding, Inc.
- Shanghai HeartCare Medical Technology Corporation Limited
- Peijia Medical Limited
- Zylox-Tonbridge Medical Technology Co., Ltd.
- Beijing Taijieweiye Technology Co., Ltd.
- Shunmei Medical Co., LTD
- Hunan Ruikangtong Technology Development Co., Ltd.
- Shandong Visee Medical Devices Co., Ltd.
- Conlife Medical Scientific (Shenzhen) Co., Ltd.
- Zhuhai NeuroSafe Medical Co., Ltd.
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Complex Coils
- Helical Coils
Segment by Application
- Intracranial Aneurysm Embolization
- Cerebral Arteriovenous Malformation Embolization
- Other Neurovascular Abnormality Embolization
Segment by Category
- Framing Coils
- Filling Coils
- Finishing Coils
- Universal Coils
Segment by Division
- Standard Coils
- Soft Coils
- Extra Soft and Super Soft Coils
MARKET DYNAMICS
Drivers
Demand is supported by the continuing clinical burden of intracranial aneurysms, broader availability of neurovascular imaging, increasing detection of previously undiagnosed aneurysms, and expansion of specialized neurointerventional treatment capacity. Endovascular coiling remains an established minimally invasive treatment pathway for many ruptured and unruptured aneurysms and retains particular clinical value where preservation of the parent artery and immediate intrasaccular occlusion are required. Increasing numbers of trained neurointerventional specialists, expansion of comprehensive stroke centers, wider adoption of advanced microcatheter systems, and growing access to neurointervention in emerging healthcare markets are supporting procedure volumes. Continuous improvements in coil softness, shape stability, packing efficiency, and detachment reliability also expand physician choice and facilitate treatment of smaller, irregular, and technically challenging aneurysms.
Restraints
The market faces significant pricing and reimbursement pressure because intracranial aneurysm embolization commonly requires multiple coils in a single procedure, making implant expenditure highly visible to hospitals and payers. Centralized procurement, tendering, reimbursement controls, and hospital cost-management programs can therefore reduce average selling prices even when procedural volumes rise. Treatment remains highly operator dependent and requires sophisticated imaging, experienced neurointerventional teams, and specialized procedural infrastructure, limiting adoption in healthcare systems with insufficient neurovascular capacity. In addition, flow-diverting stents and intrasaccular flow-disruption devices have expanded the treatment options available for selected aneurysm anatomies, particularly complex and wide-neck lesions, creating substitution pressure on conventional coil-only procedures in some clinical segments.
Opportunities
The strongest structural opportunities lie in broader neurointerventional penetration in Asia Pacific and other underserved markets, continued localization of manufacturing, and expansion of differentiated coil portfolios across multiple price and performance tiers. Products that combine low radial force with stable framing, higher volumetric filling, smaller delivery profiles, and predictable detachment can address unmet needs in small, irregular, distal, and difficult-to-pack aneurysms. Hydrogel-enhanced, fiber-enhanced, and other advanced coil technologies also provide opportunities to improve packing characteristics and support premium positioning where clinical evidence justifies differentiated performance. For Chinese manufacturers, expansion from domestic commercialization into regulated overseas markets represents an additional growth pathway, while multinational companies can benefit from broader hospital access, integrated aneurysm treatment portfolios, and region-specific product configurations.
Challenges
Neurovascular Embolization Coils require extremely consistent performance because deployment takes place within fragile intracranial vessels and aneurysm sacs where device deformation, premature detachment, migration, excessive radial force, or delivery resistance can result in serious clinical consequences. Manufacturers therefore face stringent requirements for raw-material consistency, microcoil forming, joint integrity, detachment reliability, fatigue performance, sterility, packaging, traceability, and post-market surveillance. Commercial success also depends on obtaining regulatory approvals across multiple jurisdictions while maintaining extensive physician training and clinical support. At the same time, intensifying competition among global platforms and emerging domestic manufacturers is increasing pressure on pricing and product refresh cycles, while the growing use of alternative aneurysm technologies requires coil manufacturers to demonstrate continued clinical relevance rather than relying solely on established procedure volumes.
INDUSTRY CHAIN ANALYSIS
The upstream supply chain for Neurovascular Embolization Coils is concentrated in high-specification medical-grade materials and precision components. Key inputs include platinum and platinum-based alloy wire, tungsten-containing radiopaque alloys, stainless steel or other delivery-wire materials, polymer fibers, hydrogel or specialty polymer materials, micro-scale joining and detachment components, medical-grade packaging, and sterilization services. Material purity, wire dimensional control, mechanical properties, radiopacity, biocompatibility, and lot-to-lot consistency directly influence implant performance. Manufacturing requires precision wire processing, primary and secondary coil forming, shape setting, micro-welding or joining, detachment-interface assembly, surface treatment, cleanroom assembly, inspection, packaging, sterilization, and extensive mechanical and functional validation. These processes create meaningful technical barriers despite the relatively small physical size of the final implant.
The midstream value pool is concentrated in proprietary coil design, manufacturing know-how, detachment technology, quality systems, regulatory registrations, clinical evidence, and physician-facing commercial capabilities. Downstream demand is generated primarily by tertiary hospitals, comprehensive stroke centers, academic medical centers, and other hospitals with established neurointerventional capabilities. A significant share of value is therefore created outside raw materials themselves: intellectual property, validated manufacturing processes, regulatory compliance, clinical education, procedural support, and hospital access account for a substantial portion of the economic value of the final product. Direct sales are important in large developed markets and major hospital accounts, while distributors remain significant in smaller and geographically fragmented markets.
SEGMENT INSIGHTS
By coil shape, complex three-dimensional coils represent the central commercial category because their spatial configurations are designed to establish a stable framework, improve aneurysm-wall apposition, and support subsequent filling, while helical coils remain an important complementary option for versatile filling and finishing. By embolization role, product portfolios are increasingly structured around framing, filling, and finishing functions, although certain coil families are designed for use across multiple stages. Softness has also become a major competitive variable, with standard or structurally supportive coils used where framing stability is required and progressively softer coils used to occupy residual spaces while reducing force against the aneurysm wall.
By technology, bare-metal platinum and platinum-alloy detachable coils continue to form the core market, while polymer- or hydrogel-enhanced products represent a differentiated segment focused on higher volumetric filling or modified thrombogenic characteristics. Mechanical and electrolytic detachment technologies both maintain established commercial positions, making reliability, deployment speed, repositionability, and compatibility with existing hospital workflows important purchasing considerations. Size architecture is another major source of differentiation: broad portfolios spanning small-diameter finishing coils through longer and higher-volume framing or filling coils allow suppliers to cover a greater proportion of procedural requirements and strengthen their position within hospital accounts.
DOWNSTREAM MARKET OPPORTUNITIES
Intracranial aneurysm treatment accounts for the dominant downstream opportunity, covering both ruptured and unruptured aneurysms treated through endovascular coil embolization. The opportunity is increasingly differentiated by aneurysm anatomy rather than simply by procedure count. Small and irregular aneurysms create demand for ultra-soft, low-profile coils; larger aneurysms require efficient volumetric filling; and wide-neck or complex aneurysms frequently require coils to operate as part of a broader treatment strategy involving adjunctive stents or balloons. Cerebral arteriovenous malformations, arteriovenous fistulae, and other approved neurovascular embolization indications provide additional demand. Expansion of neurointerventional services into secondary regional centers and emerging healthcare systems creates further opportunity as diagnosis, referral pathways, and physician training improve.
REGIONAL INSIGHTS
Fastest-Growing Region: Asia Pacific
North America remains one of the most important high-value markets for Neurovascular Embolization Coils, supported by a mature neurointerventional infrastructure, broad access to advanced aneurysm treatment technologies, established reimbursement pathways, and extensive participation by leading multinational manufacturers. Europe also represents a mature market with sophisticated clinical practice, although procurement structures and country-level reimbursement conditions create greater pricing heterogeneity. Both regions increasingly use coils as part of multi-technology aneurysm treatment portfolios, with clinical selection influenced by lesion anatomy, physician preference, and availability of adjunctive or alternative devices.
- XX.X%CAGR*
- XXXXUS$ Million
- XXXXREGIONAL SHARE
BY TYPE,2021-2032(US $ MILLION)
Complex Coils
Helical Coils
BY APPLICATION，2021-2032(US $ MILLION）
Intracranial Aneurysm Embolization
Cerebral Arteriovenous Malformation Embolization
Other Neurovascular Abnormality Embolization
Asia Pacific is becoming increasingly important to the competitive structure of the market. Japan maintains an established neurointerventional market and domestic manufacturing base, while China combines rapid development of neurointerventional centers with growing penetration of locally manufactured coil systems. In China, centralized procurement and hospital cost control place pressure on unit pricing, but expanding product availability, increased procedural accessibility, and accelerated domestic substitution support unit demand. Chinese manufacturers are also extending regulatory registrations beyond their domestic market, increasing competitive interaction with multinational suppliers in selected emerging and developed markets. Other Asian markets remain more dependent on imported products and distributor networks, creating opportunities for suppliers with broad regulatory coverage and efficient regional channels.
REPORT SCOPE
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Neurovascular Embolization Coils market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
CHAPTER OUTLINE
Chapter 1: Defines the Neurovascular Embolization Coils study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Neurovascular Embolization Coils: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Neurovascular Embolization Coils Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Complex Coils
1.2.3 Helical Coils
1.3 Market Segmentation by Embolization Role
1.3.1 Global Neurovascular Embolization Coils Market Size by Embolization Role, 2021 vs 2025 vs 2032
1.3.2 Framing Coils
1.3.3 Filling Coils
1.3.4 Finishing Coils
1.3.5 Universal Coils
1.4 Market Segmentation by Coil Softness
1.4.1 Global Neurovascular Embolization Coils Market Size by Coil Softness, 2021 vs 2025 vs 2032
1.4.2 Standard Coils
1.4.3 Soft Coils
1.4.4 Extra Soft and Super Soft Coils
1.5 Market Segmentation by Detachment Mechanism
1.5.1 Global Neurovascular Embolization Coils Market Size by Detachment Mechanism, 2021 vs 2025 vs 2032
1.5.2 Mechanical Detachment Coils
1.5.3 Electrolytic Detachment Coils
1.5.4 Others
1.6 Market Segmentation by Application
1.6.1 Global Neurovascular Embolization Coils Market Size by Application, 2021 vs 2025 vs 2032
1.6.2 Intracranial Aneurysm Embolization
1.6.3 Cerebral Arteriovenous Malformation Embolization
1.6.4 Other Neurovascular Abnormality Embolization
1.7 Assumptions and Limitations
1.8 Study Objectives
1.9 Years Considered
2 Executive Summary
2.1 Global Neurovascular Embolization Coils Revenue Estimates and Forecasts (2021-2032)
2.2 Global Neurovascular Embolization Coils Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Neurovascular Embolization Coils Sales Estimates and Forecasts (2021-2032)
2.4 Global Neurovascular Embolization Coils Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)
3 Competitive Landscape
3.1 Global Neurovascular Embolization Coils Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Neurovascular Embolization Coils Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Complex Coils: Market Share by Key Manufacturers
3.5.2 Helical Coils: Market Share by Key Manufacturers
3.6 Global Neurovascular Embolization Coils Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Neurovascular Embolization Coils Sales Performance by Type
4.1.1 Global Neurovascular Embolization Coils Sales Volume by Type (2021-2032)
4.1.2 Global Neurovascular Embolization Coils Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Neurovascular Embolization Coils Sales Performance by Embolization Role
4.2.1 Global Neurovascular Embolization Coils Sales Volume by Embolization Role (2021-2032)
4.2.2 Global Neurovascular Embolization Coils Revenue by Embolization Role (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Embolization Role (2021-2032)
4.3 Global Neurovascular Embolization Coils Sales Performance by Coil Softness
4.3.1 Global Neurovascular Embolization Coils Sales Volume by Coil Softness (2021-2032)
4.3.2 Global Neurovascular Embolization Coils Revenue by Coil Softness (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Coil Softness (2021-2032)
4.4 Global Neurovascular Embolization Coils Sales Performance by Detachment Mechanism
4.4.1 Global Neurovascular Embolization Coils Sales Volume by Detachment Mechanism (2021-2032)
4.4.2 Global Neurovascular Embolization Coils Revenue by Detachment Mechanism (2021-2032)
4.4.3 Global Average Selling Price (ASP) Trends by Detachment Mechanism (2021-2032)
4.5 Product Technology Differentiation
4.6 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.6.1 High-Growth Niches and Adoption Drivers
4.6.2 Profitability Hotspots and Cost Drivers
4.6.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Neurovascular Embolization Coils Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Neurovascular Embolization Coils Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Neurovascular Embolization Coils Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Neurovascular Embolization Coils Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Neurovascular Embolization Coils Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Neurovascular Embolization Coils Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Neurovascular Embolization Coils Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Neurovascular Embolization Coils Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Neurovascular Embolization Coils Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Neurovascular Embolization Coils Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Neurovascular Embolization Coils Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Neurovascular Embolization Coils Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Stryker Corporation
11.1.1 Stryker Corporation Corporation Information
11.1.2 Stryker Corporation Business Overview
11.1.3 Stryker Corporation Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.1.4 Stryker Corporation Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Stryker Corporation Neurovascular Embolization Coils Sales by Product in 2025
11.1.6 Stryker Corporation Neurovascular Embolization Coils Sales by Application in 2025
11.1.7 Stryker Corporation Neurovascular Embolization Coils Sales by Geographic Area in 2025
11.1.8 Stryker Corporation Neurovascular Embolization Coils SWOT Analysis
11.1.9 Stryker Corporation Recent Developments
11.2 Medtronic plc
11.2.1 Medtronic plc Corporation Information
11.2.2 Medtronic plc Business Overview
11.2.3 Medtronic plc Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.2.4 Medtronic plc Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Medtronic plc Neurovascular Embolization Coils Sales by Product in 2025
11.2.6 Medtronic plc Neurovascular Embolization Coils Sales by Application in 2025
11.2.7 Medtronic plc Neurovascular Embolization Coils Sales by Geographic Area in 2025
11.2.8 Medtronic plc Neurovascular Embolization Coils SWOT Analysis
11.2.9 Medtronic plc Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.3.4 Johnson & Johnson Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Johnson & Johnson Neurovascular Embolization Coils Sales by Product in 2025
11.3.6 Johnson & Johnson Neurovascular Embolization Coils Sales by Application in 2025
11.3.7 Johnson & Johnson Neurovascular Embolization Coils Sales by Geographic Area in 2025
11.3.8 Johnson & Johnson Neurovascular Embolization Coils SWOT Analysis
11.3.9 Johnson & Johnson Recent Developments
11.4 Terumo Corporation
11.4.1 Terumo Corporation Corporation Information
11.4.2 Terumo Corporation Business Overview
11.4.3 Terumo Corporation Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.4.4 Terumo Corporation Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Terumo Corporation Neurovascular Embolization Coils Sales by Product in 2025
11.4.6 Terumo Corporation Neurovascular Embolization Coils Sales by Application in 2025
11.4.7 Terumo Corporation Neurovascular Embolization Coils Sales by Geographic Area in 2025
11.4.8 Terumo Corporation Neurovascular Embolization Coils SWOT Analysis
11.4.9 Terumo Corporation Recent Developments
11.5 Penumbra, Inc.
11.5.1 Penumbra, Inc. Corporation Information
11.5.2 Penumbra, Inc. Business Overview
11.5.3 Penumbra, Inc. Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.5.4 Penumbra, Inc. Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Penumbra, Inc. Neurovascular Embolization Coils Sales by Product in 2025
11.5.6 Penumbra, Inc. Neurovascular Embolization Coils Sales by Application in 2025
11.5.7 Penumbra, Inc. Neurovascular Embolization Coils Sales by Geographic Area in 2025
11.5.8 Penumbra, Inc. Neurovascular Embolization Coils SWOT Analysis
11.5.9 Penumbra, Inc. Recent Developments
11.6 Balt Group
11.6.1 Balt Group Corporation Information
11.6.2 Balt Group Business Overview
11.6.3 Balt Group Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.6.4 Balt Group Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Balt Group Recent Developments
11.7 Kaneka Corporation
11.7.1 Kaneka Corporation Corporation Information
11.7.2 Kaneka Corporation Business Overview
11.7.3 Kaneka Corporation Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.7.4 Kaneka Corporation Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Kaneka Corporation Recent Developments
11.8 Genesis MedTech Group
11.8.1 Genesis MedTech Group Corporation Information
11.8.2 Genesis MedTech Group Business Overview
11.8.3 Genesis MedTech Group Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.8.4 Genesis MedTech Group Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Genesis MedTech Group Recent Developments
11.9 MicroPort NeuroScientific Corporation
11.9.1 MicroPort NeuroScientific Corporation Corporation Information
11.9.2 MicroPort NeuroScientific Corporation Business Overview
11.9.3 MicroPort NeuroScientific Corporation Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.9.4 MicroPort NeuroScientific Corporation Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 MicroPort NeuroScientific Corporation Recent Developments
11.10 Wallaby Medical Holding, Inc.
11.10.1 Wallaby Medical Holding, Inc. Corporation Information
11.10.2 Wallaby Medical Holding, Inc. Business Overview
11.10.3 Wallaby Medical Holding, Inc. Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.10.4 Wallaby Medical Holding, Inc. Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Wallaby Medical Holding, Inc. Recent Developments
11.11 Shanghai HeartCare Medical Technology Corporation Limited
11.11.1 Shanghai HeartCare Medical Technology Corporation Limited Corporation Information
11.11.2 Shanghai HeartCare Medical Technology Corporation Limited Business Overview
11.11.3 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.11.4 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Shanghai HeartCare Medical Technology Corporation Limited Recent Developments
11.12 Peijia Medical Limited
11.12.1 Peijia Medical Limited Corporation Information
11.12.2 Peijia Medical Limited Business Overview
11.12.3 Peijia Medical Limited Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.12.4 Peijia Medical Limited Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Peijia Medical Limited Recent Developments
11.13 Zylox-Tonbridge Medical Technology Co., Ltd.
11.13.1 Zylox-Tonbridge Medical Technology Co., Ltd. Corporation Information
11.13.2 Zylox-Tonbridge Medical Technology Co., Ltd. Business Overview
11.13.3 Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.13.4 Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Zylox-Tonbridge Medical Technology Co., Ltd. Recent Developments
11.14 Beijing Taijieweiye Technology Co., Ltd.
11.14.1 Beijing Taijieweiye Technology Co., Ltd. Corporation Information
11.14.2 Beijing Taijieweiye Technology Co., Ltd. Business Overview
11.14.3 Beijing Taijieweiye Technology Co., Ltd. Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.14.4 Beijing Taijieweiye Technology Co., Ltd. Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Beijing Taijieweiye Technology Co., Ltd. Recent Developments
11.15 Shunmei Medical Co., LTD
11.15.1 Shunmei Medical Co., LTD Corporation Information
11.15.2 Shunmei Medical Co., LTD Business Overview
11.15.3 Shunmei Medical Co., LTD Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.15.4 Shunmei Medical Co., LTD Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Shunmei Medical Co., LTD Recent Developments
11.16 Hunan Ruikangtong Technology Development Co., Ltd.
11.16.1 Hunan Ruikangtong Technology Development Co., Ltd. Corporation Information
11.16.2 Hunan Ruikangtong Technology Development Co., Ltd. Business Overview
11.16.3 Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.16.4 Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Hunan Ruikangtong Technology Development Co., Ltd. Recent Developments
11.17 Shandong Visee Medical Devices Co., Ltd.
11.17.1 Shandong Visee Medical Devices Co., Ltd. Corporation Information
11.17.2 Shandong Visee Medical Devices Co., Ltd. Business Overview
11.17.3 Shandong Visee Medical Devices Co., Ltd. Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.17.4 Shandong Visee Medical Devices Co., Ltd. Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Shandong Visee Medical Devices Co., Ltd. Recent Developments
11.18 Conlife Medical Scientific (Shenzhen) Co., Ltd.
11.18.1 Conlife Medical Scientific (Shenzhen) Co., Ltd. Corporation Information
11.18.2 Conlife Medical Scientific (Shenzhen) Co., Ltd. Business Overview
11.18.3 Conlife Medical Scientific (Shenzhen) Co., Ltd. Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.18.4 Conlife Medical Scientific (Shenzhen) Co., Ltd. Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Conlife Medical Scientific (Shenzhen) Co., Ltd. Recent Developments
11.19 Zhuhai NeuroSafe Medical Co., Ltd.
11.19.1 Zhuhai NeuroSafe Medical Co., Ltd. Corporation Information
11.19.2 Zhuhai NeuroSafe Medical Co., Ltd. Business Overview
11.19.3 Zhuhai NeuroSafe Medical Co., Ltd. Neurovascular Embolization Coils Product Models, Descriptions and Specifications
11.19.4 Zhuhai NeuroSafe Medical Co., Ltd. Neurovascular Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Zhuhai NeuroSafe Medical Co., Ltd. Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Neurovascular Embolization Coils Industry Chain
12.2 Neurovascular Embolization Coils Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Neurovascular Embolization Coils Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Neurovascular Embolization Coils Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Neurovascular Embolization Coils Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs
14 Key Findings in the Global Neurovascular Embolization Coils Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Neurovascular Embolization Coils Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Neurovascular Embolization Coils Market Size Growth Rate by Embolization Role, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Neurovascular Embolization Coils Market Size Growth Rate by Coil Softness, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Neurovascular Embolization Coils Market Size Growth Rate by Detachment Mechanism, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Neurovascular Embolization Coils Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Neurovascular Embolization Coils Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 7. Global Neurovascular Embolization Coils Revenue by Region (US$ Million), 2021-2026
Table 8. Global Neurovascular Embolization Coils Revenue by Region (US$ Million), 2027-2032
Table 9. Global Neurovascular Embolization Coils Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 10. Global Neurovascular Embolization Coils Sales by Region (K Units), 2021-2026
Table 11. Global Neurovascular Embolization Coils Sales by Region (K Units), 2027-2032
Table 12. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 13. Global Neurovascular Embolization Coils Sales by Manufacturers (K Units), 2021-2026
Table 14. Global Neurovascular Embolization Coils Sales Share by Manufacturers (2021-2026)
Table 15. Global Neurovascular Embolization Coils Revenue by Manufacturers (US$ Million), 2021-2026
Table 16. Global Neurovascular Embolization Coils Revenue-Based Market Share by Manufacturers (2021-2026)
Table 17. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 18. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Neurovascular Embolization Coils Revenue, 2025
Table 19. Global Neurovascular Embolization Coils Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 20. Global Neurovascular Embolization Coils Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 21. Key Manufacturers Neurovascular Embolization Coils Manufacturing Base and Headquarters
Table 22. Global Neurovascular Embolization Coils Market Concentration Ratio (CR5)
Table 23. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Neurovascular Embolization Coils Sales Volume by Type (K Units), 2021-2026
Table 26. Global Neurovascular Embolization Coils Sales Volume by Type (K Units), 2027-2032
Table 27. Global Neurovascular Embolization Coils Revenue by Type (US$ Million), 2021-2026
Table 28. Global Neurovascular Embolization Coils Revenue by Type (US$ Million), 2027-2032
Table 29. Global Neurovascular Embolization Coils Sales Volume by Embolization Role (K Units), 2021-2026
Table 30. Global Neurovascular Embolization Coils Sales Volume by Embolization Role (K Units), 2027-2032
Table 31. Global Neurovascular Embolization Coils Revenue by Embolization Role (US$ Million), 2021-2026
Table 32. Global Neurovascular Embolization Coils Revenue by Embolization Role (US$ Million), 2027-2032
Table 33. Global Neurovascular Embolization Coils Sales Volume by Coil Softness (K Units), 2021-2026
Table 34. Global Neurovascular Embolization Coils Sales Volume by Coil Softness (K Units), 2027-2032
Table 35. Global Neurovascular Embolization Coils Revenue by Coil Softness (US$ Million), 2021-2026
Table 36. Global Neurovascular Embolization Coils Revenue by Coil Softness (US$ Million), 2027-2032
Table 37. Global Neurovascular Embolization Coils Sales Volume by Detachment Mechanism (K Units), 2021-2026
Table 38. Global Neurovascular Embolization Coils Sales Volume by Detachment Mechanism (K Units), 2027-2032
Table 39. Global Neurovascular Embolization Coils Revenue by Detachment Mechanism (US$ Million), 2021-2026
Table 40. Global Neurovascular Embolization Coils Revenue by Detachment Mechanism (US$ Million), 2027-2032
Table 41. Technical Specifications by Key Product Type
Table 42. Global Neurovascular Embolization Coils Sales by Application (K Units), 2021-2026
Table 43. Global Neurovascular Embolization Coils Sales by Application (K Units), 2027-2032
Table 44. Neurovascular Embolization Coils High-Growth Sectors Demand CAGR (2026-2032)
Table 45. Global Neurovascular Embolization Coils Revenue by Application (US$ Million), 2021-2026
Table 46. Global Neurovascular Embolization Coils Revenue by Application (US$ Million), 2027-2032
Table 47. Top Customers by Region
Table 48. Top Customers by Application
Table 49. North America Neurovascular Embolization Coils Growth Accelerators and Market Barriers
Table 50. North America Neurovascular Embolization Coils Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 51. North America Neurovascular Embolization Coils Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Europe Neurovascular Embolization Coils Growth Accelerators and Market Barriers
Table 53. Europe Neurovascular Embolization Coils Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Europe Neurovascular Embolization Coils Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 55. Asia-Pacific Neurovascular Embolization Coils Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 56. Asia-Pacific Neurovascular Embolization Coils Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 57. Asia-Pacific Neurovascular Embolization Coils Growth Accelerators and Market Barriers
Table 58. Southeast Asia Neurovascular Embolization Coils Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 59. Central and South America Neurovascular Embolization Coils Investment Opportunities and Key Challenges
Table 60. Central and South America Neurovascular Embolization Coils Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 61. Middle East and Africa Neurovascular Embolization Coils Investment Opportunities and Key Challenges
Table 62. Middle East and Africa Neurovascular Embolization Coils Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 63. Stryker Corporation Corporation Information
Table 64. Stryker Corporation Description and Major Businesses
Table 65. Stryker Corporation Product Models, Descriptions and Specifications
Table 66. Stryker Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 67. Stryker Corporation Sales Value Proportion by Product in 2025
Table 68. Stryker Corporation Sales Value Proportion by Application in 2025
Table 69. Stryker Corporation Sales Value Proportion by Geographic Area in 2025
Table 70. Stryker Corporation Neurovascular Embolization Coils SWOT Analysis
Table 71. Stryker Corporation Recent Developments
Table 72. Medtronic plc Corporation Information
Table 73. Medtronic plc Description and Major Businesses
Table 74. Medtronic plc Product Models, Descriptions and Specifications
Table 75. Medtronic plc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Medtronic plc Sales Value Proportion by Product in 2025
Table 77. Medtronic plc Sales Value Proportion by Application in 2025
Table 78. Medtronic plc Sales Value Proportion by Geographic Area in 2025
Table 79. Medtronic plc Neurovascular Embolization Coils SWOT Analysis
Table 80. Medtronic plc Recent Developments
Table 81. Johnson & Johnson Corporation Information
Table 82. Johnson & Johnson Description and Major Businesses
Table 83. Johnson & Johnson Product Models, Descriptions and Specifications
Table 84. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Johnson & Johnson Sales Value Proportion by Product in 2025
Table 86. Johnson & Johnson Sales Value Proportion by Application in 2025
Table 87. Johnson & Johnson Sales Value Proportion by Geographic Area in 2025
Table 88. Johnson & Johnson Neurovascular Embolization Coils SWOT Analysis
Table 89. Johnson & Johnson Recent Developments
Table 90. Terumo Corporation Corporation Information
Table 91. Terumo Corporation Description and Major Businesses
Table 92. Terumo Corporation Product Models, Descriptions and Specifications
Table 93. Terumo Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Terumo Corporation Sales Value Proportion by Product in 2025
Table 95. Terumo Corporation Sales Value Proportion by Application in 2025
Table 96. Terumo Corporation Sales Value Proportion by Geographic Area in 2025
Table 97. Terumo Corporation Neurovascular Embolization Coils SWOT Analysis
Table 98. Terumo Corporation Recent Developments
Table 99. Penumbra, Inc. Corporation Information
Table 100. Penumbra, Inc. Description and Major Businesses
Table 101. Penumbra, Inc. Product Models, Descriptions and Specifications
Table 102. Penumbra, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Penumbra, Inc. Sales Value Proportion by Product in 2025
Table 104. Penumbra, Inc. Sales Value Proportion by Application in 2025
Table 105. Penumbra, Inc. Sales Value Proportion by Geographic Area in 2025
Table 106. Penumbra, Inc. Neurovascular Embolization Coils SWOT Analysis
Table 107. Penumbra, Inc. Recent Developments
Table 108. Balt Group Corporation Information
Table 109. Balt Group Description and Major Businesses
Table 110. Balt Group Product Models, Descriptions and Specifications
Table 111. Balt Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Balt Group Recent Developments
Table 113. Kaneka Corporation Corporation Information
Table 114. Kaneka Corporation Description and Major Businesses
Table 115. Kaneka Corporation Product Models, Descriptions and Specifications
Table 116. Kaneka Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Kaneka Corporation Recent Developments
Table 118. Genesis MedTech Group Corporation Information
Table 119. Genesis MedTech Group Description and Major Businesses
Table 120. Genesis MedTech Group Product Models, Descriptions and Specifications
Table 121. Genesis MedTech Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Genesis MedTech Group Recent Developments
Table 123. MicroPort NeuroScientific Corporation Corporation Information
Table 124. MicroPort NeuroScientific Corporation Description and Major Businesses
Table 125. MicroPort NeuroScientific Corporation Product Models, Descriptions and Specifications
Table 126. MicroPort NeuroScientific Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. MicroPort NeuroScientific Corporation Recent Developments
Table 128. Wallaby Medical Holding, Inc. Corporation Information
Table 129. Wallaby Medical Holding, Inc. Description and Major Businesses
Table 130. Wallaby Medical Holding, Inc. Product Models, Descriptions and Specifications
Table 131. Wallaby Medical Holding, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Wallaby Medical Holding, Inc. Recent Developments
Table 133. Shanghai HeartCare Medical Technology Corporation Limited Corporation Information
Table 134. Shanghai HeartCare Medical Technology Corporation Limited Description and Major Businesses
Table 135. Shanghai HeartCare Medical Technology Corporation Limited Product Models, Descriptions and Specifications
Table 136. Shanghai HeartCare Medical Technology Corporation Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Shanghai HeartCare Medical Technology Corporation Limited Recent Developments
Table 138. Peijia Medical Limited Corporation Information
Table 139. Peijia Medical Limited Description and Major Businesses
Table 140. Peijia Medical Limited Product Models, Descriptions and Specifications
Table 141. Peijia Medical Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Peijia Medical Limited Recent Developments
Table 143. Zylox-Tonbridge Medical Technology Co., Ltd. Corporation Information
Table 144. Zylox-Tonbridge Medical Technology Co., Ltd. Description and Major Businesses
Table 145. Zylox-Tonbridge Medical Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 146. Zylox-Tonbridge Medical Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Zylox-Tonbridge Medical Technology Co., Ltd. Recent Developments
Table 148. Beijing Taijieweiye Technology Co., Ltd. Corporation Information
Table 149. Beijing Taijieweiye Technology Co., Ltd. Description and Major Businesses
Table 150. Beijing Taijieweiye Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 151. Beijing Taijieweiye Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Beijing Taijieweiye Technology Co., Ltd. Recent Developments
Table 153. Shunmei Medical Co., LTD Corporation Information
Table 154. Shunmei Medical Co., LTD Description and Major Businesses
Table 155. Shunmei Medical Co., LTD Product Models, Descriptions and Specifications
Table 156. Shunmei Medical Co., LTD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Shunmei Medical Co., LTD Recent Developments
Table 158. Hunan Ruikangtong Technology Development Co., Ltd. Corporation Information
Table 159. Hunan Ruikangtong Technology Development Co., Ltd. Description and Major Businesses
Table 160. Hunan Ruikangtong Technology Development Co., Ltd. Product Models, Descriptions and Specifications
Table 161. Hunan Ruikangtong Technology Development Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Hunan Ruikangtong Technology Development Co., Ltd. Recent Developments
Table 163. Shandong Visee Medical Devices Co., Ltd. Corporation Information
Table 164. Shandong Visee Medical Devices Co., Ltd. Description and Major Businesses
Table 165. Shandong Visee Medical Devices Co., Ltd. Product Models, Descriptions and Specifications
Table 166. Shandong Visee Medical Devices Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Shandong Visee Medical Devices Co., Ltd. Recent Developments
Table 168. Conlife Medical Scientific (Shenzhen) Co., Ltd. Corporation Information
Table 169. Conlife Medical Scientific (Shenzhen) Co., Ltd. Description and Major Businesses
Table 170. Conlife Medical Scientific (Shenzhen) Co., Ltd. Product Models, Descriptions and Specifications
Table 171. Conlife Medical Scientific (Shenzhen) Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Conlife Medical Scientific (Shenzhen) Co., Ltd. Recent Developments
Table 173. Zhuhai NeuroSafe Medical Co., Ltd. Corporation Information
Table 174. Zhuhai NeuroSafe Medical Co., Ltd. Description and Major Businesses
Table 175. Zhuhai NeuroSafe Medical Co., Ltd. Product Models, Descriptions and Specifications
Table 176. Zhuhai NeuroSafe Medical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. Zhuhai NeuroSafe Medical Co., Ltd. Recent Developments
Table 178. Key Raw Materials Distribution
Table 179. Raw Materials Key Suppliers
Table 180. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 181. Milestones in Production Technology Evolution
Table 182. Distributors List
Table 183. Market Trends and Market Evolution
Table 184. Market Drivers and Opportunities
Table 185. Market Challenges, Risks, and Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurovascular Embolization Coils Product Picture
Figure 2. Global Neurovascular Embolization Coils Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Complex Coils Product Picture
Figure 4. Helical Coils Product Picture
Figure 5. Global Neurovascular Embolization Coils Market Size Growth Rate by Embolization Role, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Framing Coils Product Picture
Figure 7. Filling Coils Product Picture
Figure 8. Finishing Coils Product Picture
Figure 9. Universal Coils Product Picture
Figure 10. Global Neurovascular Embolization Coils Market Size Growth Rate by Coil Softness, 2021 vs 2025 vs 2032 (US$ Million)
Figure 11. Standard Coils Product Picture
Figure 12. Soft Coils Product Picture
Figure 13. Extra Soft and Super Soft Coils Product Picture
Figure 14. Global Neurovascular Embolization Coils Market Size Growth Rate by Detachment Mechanism, 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Mechanical Detachment Coils Product Picture
Figure 16. Electrolytic Detachment Coils Product Picture
Figure 17. Others Product Picture
Figure 18. Global Neurovascular Embolization Coils Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 19. Intracranial Aneurysm Embolization
Figure 20. Cerebral Arteriovenous Malformation Embolization
Figure 21. Other Neurovascular Abnormality Embolization
Figure 22. Neurovascular Embolization Coils Report Years Considered
Figure 23. Global Neurovascular Embolization Coils Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 25. Global Neurovascular Embolization Coils Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 26. Global Neurovascular Embolization Coils Revenue-Based Market Share by Region (2021-2032)
Figure 27. Global Neurovascular Embolization Coils Sales (K Units), 2021-2032
Figure 28. Global Neurovascular Embolization Coils Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 29. Global Neurovascular Embolization Coils Sales Market Share by Region (2021-2032)
Figure 30. Top 5 and Top 10 Manufacturers Neurovascular Embolization Coils Sales Volume Market Share in 2025
Figure 31. Global Neurovascular Embolization Coils Revenue-Based Market Share Ranking (2025)
Figure 32. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 33. Complex Coils Revenue-Based Market Share by Manufacturer in 2025
Figure 34. Helical Coils Revenue-Based Market Share by Manufacturer in 2025
Figure 35. Global Neurovascular Embolization Coils Sales Volume-Based Market Share by Type (2021-2032)
Figure 36. Global Neurovascular Embolization Coils Revenue-Based Market Share by Type (2021-2032)
Figure 37. Global Neurovascular Embolization Coils ASP by Type (US$/Unit), 2021-2032
Figure 38. Global Neurovascular Embolization Coils Sales Volume-Based Market Share by Embolization Role (2021-2032)
Figure 39. Global Neurovascular Embolization Coils Revenue-Based Market Share by Embolization Role (2021-2032)
Figure 40. Global Neurovascular Embolization Coils ASP by Embolization Role (US$/Unit), 2021-2032
Figure 41. Global Neurovascular Embolization Coils Sales Volume-Based Market Share by Coil Softness (2021-2032)
Figure 42. Global Neurovascular Embolization Coils Revenue-Based Market Share by Coil Softness (2021-2032)
Figure 43. Global Neurovascular Embolization Coils ASP by Coil Softness (US$/Unit), 2021-2032
Figure 44. Global Neurovascular Embolization Coils Sales Volume-Based Market Share by Detachment Mechanism (2021-2032)
Figure 45. Global Neurovascular Embolization Coils Revenue-Based Market Share by Detachment Mechanism (2021-2032)
Figure 46. Global Neurovascular Embolization Coils ASP by Detachment Mechanism (US$/Unit), 2021-2032
Figure 47. Global Neurovascular Embolization Coils Sales Market Share by Application (2021-2032)
Figure 48. Global Neurovascular Embolization Coils Revenue-Based Market Share by Application (2021-2032)
Figure 49. Global Neurovascular Embolization Coils ASP by Application (US$/Unit), 2021-2032
Figure 50. North America Neurovascular Embolization Coils Sales YoY (K Units), 2021-2032
Figure 51. North America Neurovascular Embolization Coils Revenue YoY (US$ Million), 2021-2032
Figure 52. North America Top 5 Manufacturers Neurovascular Embolization Coils Sales Revenue (US$ Million) in 2025
Figure 53. North America Neurovascular Embolization Coils Sales Volume (K Units) by Application (2021-2032)
Figure 54. North America Neurovascular Embolization Coils Sales Revenue (US$ Million) by Application (2021-2032)
Figure 55. US Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 56. Canada Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 57. Mexico Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 58. Europe Neurovascular Embolization Coils Sales YoY (K Units), 2021-2032
Figure 59. Europe Neurovascular Embolization Coils Revenue YoY (US$ Million), 2021-2032
Figure 60. Europe Top 5 Manufacturers Neurovascular Embolization Coils Sales Revenue (US$ Million) in 2025
Figure 61. Europe Neurovascular Embolization Coils Sales Volume (K Units) by Application (2021-2032)
Figure 62. Europe Neurovascular Embolization Coils Sales Revenue (US$ Million) by Application (2021-2032)
Figure 63. Germany Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 64. France Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 65. U.K. Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 66. Italy Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 67. Russia Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 68. Asia-Pacific Neurovascular Embolization Coils Sales YoY (K Units), 2021-2032
Figure 69. Asia-Pacific Neurovascular Embolization Coils Revenue YoY (US$ Million), 2021-2032
Figure 70. Asia-Pacific Top 8 Manufacturers Neurovascular Embolization Coils Sales Revenue (US$ Million) in 2025
Figure 71. Asia-Pacific Neurovascular Embolization Coils Sales Volume (K Units) by Application (2021-2032)
Figure 72. Asia-Pacific Neurovascular Embolization Coils Sales Revenue (US$ Million) by Application (2021-2032)
Figure 73. Indonesia Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 74. Japan Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 75. South Korea Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 76. China Taiwan Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 77. India Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 78. Central and South America Neurovascular Embolization Coils Sales YoY (K Units), 2021-2032
Figure 79. Central and South America Neurovascular Embolization Coils Revenue YoY (US$ Million), 2021-2032
Figure 80. Central and South America Top 5 Manufacturers Neurovascular Embolization Coils Sales Revenue (US$ Million) in 2025
Figure 81. Central and South America Neurovascular Embolization Coils Sales Volume (K Units) by Application (2021-2032)
Figure 82. Central and South America Neurovascular Embolization Coils Sales Revenue (US$ Million) by Application (2021-2032)
Figure 83. Brazil Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 84. Argentina Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 85. Middle East, and Africa Neurovascular Embolization Coils Sales YoY (K Units), 2021-2032
Figure 86. Middle East and Africa Neurovascular Embolization Coils Revenue YoY (US$ Million), 2021-2032
Figure 87. Middle East and Africa Top 5 Manufacturers Neurovascular Embolization Coils Sales Revenue (US$ Million) in 2025
Figure 88. Middle East and Africa Neurovascular Embolization Coils Sales Volume (K Units) by Application (2021-2032)
Figure 89. Middle East and Africa Neurovascular Embolization Coils Sales Revenue (US$ Million) by Application (2021-2032)
Figure 90. GCC Countries Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 91. Turkey Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 92. Egypt Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 93. South Africa Neurovascular Embolization Coils Revenue (US$ Million), 2021-2032
Figure 94. Neurovascular Embolization Coils Industry Chain Mapping
Figure 95. Regional Neurovascular Embolization Coils Manufacturing Base Distribution (%)
Figure 96. Global Neurovascular Embolization Coils Production Market Share by Region (2021-2032)
Figure 97. Neurovascular Embolization Coils Production Process
Figure 98. Regional Neurovascular Embolization Coils Production Cost Structure
Figure 99. Channels of Distribution (Direct Vs Distribution)
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Neurovascular Embolization Coils market size from 2026 to 2032?
The annual compound growth rate of the global Neurovascular Embolization Coils market is 5.6% 2026 to 2032.
Which region is expected to have the highest market share?
Which companies rank high in the global Neurovascular Embolization Coils market?
What was the global market size of Neurovascular Embolization Coils in 2026?
What was the global market size of Neurovascular Embolization Coils in 2032?
Related Reports
Global Neurovascular Embolization Coils Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Neurovascular Embolization Coils market size was US$ 1058 million in 2025 and is forecast to reach a readjusted size of US$ 1553 million by 2032 with a CAGR of 5.6% during the forecast period 2026-2032.
Published Date: 2026-08-23
Pages: 150
USD 4250.00
(Single User License)
Neurovascular Embolization Coils- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Neurovascular Embolization Coils was estimated to be worth US$ 1058 million in 2025 and is projected to reach US$ 1553 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published Date: 2026-08-23
Pages: 152
USD 3950.00
(Single User License)
Global Neurovascular Embolization Coils Market Research Report 2026
The global Neurovascular Embolization Coils market was valued at US$ 1058 million in 2025 and is anticipated to reach US$ 1553 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Published Date: 2026-08-23
Pages: 135
USD 2900.00
(Single User License)
Global Neurovascular Embolization Coils Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Neurovascular Embolization Coils market size was US$ 118 million in 2024 and is forecast to a readjusted size of US$ 146 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
Global Neurovascular Embolization Coils Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Neurovascular Embolization Coils market is projected to grow from US$ 118 million in 2024 to US$ 146 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 135
USD 4900.00
(Single User License)
Global Neurovascular Embolization Coils Market Research Report 2025
The global market for Neurovascular Embolization Coils was valued at US$ 118 million in the year 2024 and is projected to reach a revised size of US$ 146 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-01-16
Pages: 85
USD 2900.00
(Single User License)
Neurovascular Embolization Coils- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neurovascular Embolization Coils was estimated to be worth US$ 118 million in 2024 and is forecast to a readjusted size of US$ 146 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 97
USD 3950.00
(Single User License)
Global Neurovascular Embolization Coils Market Insights, Forecast to 2030
Neurovascular Embolization Coils are used to treat a wide range of neurovascular lesions, including small, medium, and large-sized aneurysms.
Published Date: 2024-04-12
Pages: 113
USD 4900.00
(Single User License)
Global Neurovascular Embolization Coils Market Research Report 2024
Neurovascular Embolization Coils are used to treat a wide range of neurovascular lesions, including small, medium, and large-sized aneurysms.
Published Date: 2024-01-17
Pages: 93
USD 2900.00
(Single User License)
Neurovascular Embolization Coils - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Neurovascular Embolization Coils are used to treat a wide range of neurovascular lesions, including small, medium, and large-sized aneurysms.
Published Date: 2024-01-10
Pages: 123
USD 3950.00
(Single User License)
Global Neurovascular Embolization Coils Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Neurovascular Embolization Coils market size was US$ 1058 million in 2025 and is forecast to reach a readjusted size of US$ 1553 million by 2032 with a CAGR of 5.6% during the forecast period 2026-2032.
Published: 2026-08-23
Pages: 150
USD 4250.00 (Single User License)Neurovascular Embolization Coils- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Neurovascular Embolization Coils was estimated to be worth US$ 1058 million in 2025 and is projected to reach US$ 1553 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-08-23
Pages: 152
USD 3950.00 (Single User License)Global Neurovascular Embolization Coils Market Research Report 2026
The global Neurovascular Embolization Coils market was valued at US$ 1058 million in 2025 and is anticipated to reach US$ 1553 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-08-23
Pages: 135
USD 2900.00 (Single User License)Global Neurovascular Embolization Coils Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Neurovascular Embolization Coils market size was US$ 118 million in 2024 and is forecast to a readjusted size of US$ 146 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
USD 4250.00 (Single User License)Global Neurovascular Embolization Coils Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Neurovascular Embolization Coils market is projected to grow from US$ 118 million in 2024 to US$ 146 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 135
USD 4900.00 (Single User License)Global Neurovascular Embolization Coils Market Research Report 2025
The global market for Neurovascular Embolization Coils was valued at US$ 118 million in the year 2024 and is projected to reach a revised size of US$ 146 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-01-16
Pages: 85
USD 2900.00 (Single User License)Neurovascular Embolization Coils- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neurovascular Embolization Coils was estimated to be worth US$ 118 million in 2024 and is forecast to a readjusted size of US$ 146 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 97
USD 3950.00 (Single User License)Global Neurovascular Embolization Coils Market Insights, Forecast to 2030
Neurovascular Embolization Coils are used to treat a wide range of neurovascular lesions, including small, medium, and large-sized aneurysms.
Published: 2024-04-12
Pages: 113
USD 4900.00 (Single User License)Global Neurovascular Embolization Coils Market Research Report 2024
Neurovascular Embolization Coils are used to treat a wide range of neurovascular lesions, including small, medium, and large-sized aneurysms.
Published: 2024-01-17
Pages: 93
USD 2900.00 (Single User License)Neurovascular Embolization Coils - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Neurovascular Embolization Coils are used to treat a wide range of neurovascular lesions, including small, medium, and large-sized aneurysms.
Published: 2024-01-10
Pages: 123
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
KEY FINDINGS
OVERVIEW
MARKET TRENDS
MARKET SEGMENTATION
MARKET DYNAMICS
INDUSTRY CHAIN ANALYSIS
SEGMENT INSIGHTS
DOWNSTREAM MARKET OPPORTUNITIES
REGIONAL INSIGHTS
REPORT SCOPE
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now